跳至主要内容
临床试验/NCT02666820
NCT02666820已完成不适用

Endoscopic Papillary Large Balloon Dilatation Versus Sphincterotomy +/- Mechanical Lithotripsy for Removal of Bile Duct Stones With a Mean Stone > 20 mm : A Randomized Controlled Study

Prince of Songkla University2 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
85
试验地点
2
主要终点
Complete stone clearance rate in the index ERCP

研究概览

简要总结

Endoscopic sphincterotomy (EST) combined with large balloon dilation (LBD) has been increasingly accepted as alternative method for removal of large bile duct stones. However, there were limited studies comparing the efficacy of EST in combined with LBD to EST with mechanical lithotripsy (ML). The purpose of this study to compare the efficacy and safety of combined EST- LBD versus EST-ML in the removal of very large bile duct stones.

详细描述

The large common bile duct stones (CBDS) remains a therapeutic challenge in ERCPs. Large CBDS are generally refractory to be removed by EST and stone extraction balloons and or baskets. Traditional rescue therapy was the technique of stone fragmentation using ML. The previous reports have shown that EST with ML was successful in the fragmentation of large stones yielding stone clearance rate from 68 t0 79 %. EST-LBD has been shown favorable outcome in the treatment of large bile duct stone. A meta-analysis comparing the effectiveness and complications between EST-LBD and EST in the management of CBDS showed that EST-LBD was as effective as EST for the removal of large or difficult of CBDS in terms of stone clearance in the first ERCP session of 87.87 % vs. 84.15 % and overall clearance of 97.35 % vs. 96.35 % but EST-LBD was associated with fewer complications as well as reduced need for ML compared to EST. The efficacy of EST-ML versus EST-LBD as a therapy for relatively large CBDS, a mean stone size > 20 mm in currently not well defined. The investigators, herein, compared the efficacy and complications between EST followed by LBD or ML for the removal of CBDS > 15 mm with a mean stone size > 20 mm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with age>/= 18 years with confirmed or suspected CBDS at our institute were enrolled in the study.
  • Informed consent was obtained in every patients prior to the procedure
  • Patients were randomized to LBD or ML if they had CBD stone >/= 15 mm in shortest dimension or stone' size was disproportionate to the lower bile duct segment with a ratio of largest stone dimension/lower bile duct segment diameter > 50 % identified by a cholangiogram at ERCP.

排除标准

  • pregnant woman
  • uncorrectable coagulopathy (INR >1.5 ), thrombocytopenia( platelet count < 50,000)
  • concomitant intrahepatic duct stones
  • ongoing acute pancreatitis or acute cholecystitis
  • surgically altered anatomy (i.e. Billroth II or Roux-en-Y reconstruction)
  • concomitant pancreatic or biliary malignancy

结局指标

主要结局

Complete stone clearance rate in the index ERCP

时间窗: 24 hours

The number of patients who was achieved complete stone clearance in the index ERCP

次要结局

  • Complete stone clearance rate in the rescue therapy(24 hours)
  • Procedure time(24 hours)
  • Complication rate(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nisa Netinatsunton

Principal Investigator

Prince of Songkla University

研究点 (2)

Loading locations...

相似试验